NCT01173757View on ClinicalTrials.gov

To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy
Interventions
DRUG

PF-04995274

Single dose of up to 5 mg PF-04995274, delivered in solution on study day 1

Trial Locations (3)

06511

Pfizer Investigational Site, New Haven

06519

Pfizer Investigational Site, New Haven

06520

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01173757 - To Evaluate The Relationship Between Plasma Drug Levels And Receptor Binding In Brain Using PET (Positron Emission Tomography) In Healthy Volunteers | Biotech Hunter | Biotech Hunter